Cargando…

Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children

BACKGROUND & AIMS: Recent studies have shown that patients with manifest non-alcoholic fatty liver disease (NAFLD), e.g. steatosis grade 3 or steatohepatitis with or without beginning fibrosis frequently show altered fecal microbiota composition and elevated bacterial endotoxin levels. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nier, Anika, Engstler, Anna Janina, Maier, Ina Barbara, Bergheim, Ina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589126/ https://www.ncbi.nlm.nih.gov/pubmed/28880885 http://dx.doi.org/10.1371/journal.pone.0183282

Ejemplares similares

Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern
por: Nier, Anika, et al.
Publicado: (2018)

Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance
por: Rajcic, Dragana, et al.
Publicado: (2020)

Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non‐alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2022)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease
por: Jung, Finn, et al.
Publicado: (2021)

Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
por: Brandt, Annette, et al.
Publicado: (2019)

Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance
por: Sánchez, Victor, et al.
Publicado: (2021)

Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis
por: Sellmann, Cathrin, et al.
Publicado: (2017)

The Frequent Adiponutrin (PNPLA3) Variant p.Ile148Met Is Associated with Early Liver Injury: Analysis of a German Pediatric Cohort
por: Krawczyk, Marcin, et al.
Publicado: (2015)

Short‐Term Isocaloric Intake of a Fructose‐ but not Glucose‐Rich Diet Affects Bacterial Endotoxin Concentrations and Markers of Metabolic Health in Normal Weight Healthy Subjects
por: Nier, Anika, et al.
Publicado: (2019)

In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kanuri, Giridhar, et al.
Publicado: (2013)

Metabolic Abnormalities in Normal Weight Children Are Associated with Increased Visceral Fat Accumulation, Elevated Plasma Endotoxin Levels and a Higher Monosaccharide Intake
por: Nier, Anika, et al.
Publicado: (2019)

Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2021)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function
por: Brandt, Annette, et al.
Publicado: (2018)

Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase
por: Rajcic, Dragana, et al.
Publicado: (2021)

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis
por: Baumann, Anja, et al.
Publicado: (2020)

Beneficial Effects of Vitamin D Treatment in an Obese Mouse Model of Non-Alcoholic Steatohepatitis
por: Jahn, Daniel, et al.
Publicado: (2019)

Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment
por: Brandt, Annette, et al.
Publicado: (2017)

Impairments of intestinal arginine and NO metabolisms trigger aging-associated intestinal barrier dysfunction and ‘inflammaging'
por: Brandt, Annette, et al.
Publicado: (2022)

Lactobacillus rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in Mice
por: Ritze, Yvonne, et al.
Publicado: (2014)

The Intestinal Barrier Dysfunction as Driving Factor of Inflammaging
por: Untersmayr, Eva, et al.
Publicado: (2022)

Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation
por: Nicoletti, Alberto, et al.
Publicado: (2019)

Fructose: a modulator of intestinal barrier function and hepatic health?
por: Staltner, Raphaela, et al.
Publicado: (2023)

Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice
por: Jung, Finn, et al.
Publicado: (2019)

Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease
por: Biolato, Marco, et al.
Publicado: (2019)

Positive effect of an electrolyzed reduced water on gut permeability, fecal microbiota and liver in an animal model of Parkinson’s disease
por: Bordoni, Laura, et al.
Publicado: (2019)

Dietary pattern and leisure time activity of overweight and normal weight children in Germany: sex-specific differences
por: Maier, Ina B, et al.
Publicado: (2013)

The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease
por: Ayob, Nurainina, et al.
Publicado: (2023)

Already!
Publicado: (1892)

Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury
por: Schneider, Kai Markus, et al.
Publicado: (2020)

Validation of Malnutrition Screening Tools in Liver Cirrhosis
por: Traub, Julia, et al.
Publicado: (2020)

100 Already?
por: Negrin, Robert S.
Publicado: (2021)

Sarcopenia and Liver Cirrhosis—Comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019
por: Traub, Julia, et al.
Publicado: (2020)

Alterations in CD200-CD200R1 System during EAE Already Manifest at Presymptomatic Stages
por: Valente, Tony, et al.
Publicado: (2017)

Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes
por: Steinbrenner, Holger, et al.
Publicado: (2018)

The Booster is five already!
Publicado: (1977)

Visit the LHC... already!
Publicado: (2002)

Distribution of cytochrome P450 2C, 2E1, 3A4, and 3A5 in human colon mucosa
por: Bergheim, Ina, et al.
Publicado: (2005)

Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma
por: Bergheim, Ina, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_8qvtlgcikibhebfejaa96l8gfq